Copy of Global Burden Disease Death Estimates Sex Age 2008

World Health OrganizationOrganisation Mondiale de la Santé

Department of INTRODUCTION

Measurement and Health Information

February 2009

MORTALITY AND BURDEN OF DISEASE ESTIMATES FOR WHO MEMBER STATES IN 2004

This workbook contains estimates of mortality and burden of disease for WHO Member States for the year 2004. These estimates are are generally consistent with the regional-level results published in the report The global burden of disease: 2004 update (1), with some revisions following a consultation with Member States which took place during late 2008.

These summary tables represent the best estimates of WHO – based on evidence available in 2008 – rather than the official estimates of Member States. These estimates have been computed using standard categories and methods to ensure cross-national comparability . Therefore, they are not always the same as official national estimates, nor necessarily endorsed by specific Member States.

Methods and data sources are summarized in the Annexes of the "Global burden of disease: 2004 update" (1) and the methodology is described in more detail elsewhere (2). Mortality estimates are based on analysis of latest available national information on levels of mortality and cause distributions as at early 2008. YLD estimates are based on analyses of incidence, prevalence, duration and severity of conditions for the relevant epidemiological subregion, together with national and subnational level information available to WHO. The population estimates for WHO Member States for 2004 are those prepared by the UN Population Division in its 2006 revision (3).

WHO has previously released estimates of mortality and burden of disease for WHO Member States for the year 2002. Note that differences between the 2004 estimates and the previous 2002 estimates should not be interpreted as representing time trends. The 2002 estimates are not generally comparable with those for 2004 due to changes in methods and data. Some Member States have prepared similar estimates for a recent year that may draw on additional and more specific national data sources (4). Not all such results are comparable to the estimates included here, due to differences in definitions of cause categories, methods, disability weights and choices for discounting and age weighting.

The work leading to these statistics was undertaken by the WHO Department of Health Statistics and Informatics (IER/HSI) in collaboration with WHO technical programmes and with scientists worldwide. Documentation and regional summary tables are available on the WHO website (http://www.who.int/evidence/bod), together with software tools and a National Burden of Disease Manual providing guidelines for conducting national studies (5).

References1. 1. World Health Organization. The global burden of disease: 2004 update. Geneva, WHO, 2008. Available at www.who.int/evidence/bod2. Mathers CD, Lopez AD, Murray CJL. The burden of disease and mortality by condition: data, methods and results for 2001. In: Lopez AD, Mathers CD, Ezzati M, Murray CJL, Jamison DT, eds. Global burden of disease and risk factors. New York, Oxford University Press, 2006: 45-240. Available at http://www.dcp2.org/pubs/GBD.3. United Nations Population Division. World population prospects - the 2006 revision. 2007. New York, United Nations.4. WHO website. Links to National Burden of Disease Centres and Studies. http://www.who.int/healthinfo/global_burden_disease/tools_national/en/index.html5. Mathers CD, Vos T, Lopez AD, Ezzati M. National Burden of Disease Studies: A Practical Guide. Edition 1.1. 2001. Geneva, World Health Organization, Global Program on Evidence for Health Policy. Available at http://www.who.int/healthinfo/global_burden_disease/tools_national/en/index.html

DISABILITY ADJUSTED LIFE YEARS

The Disability Adjusted Life Year or DALY is a health gap measure that extends the concept of potential years of life lost due to premature death (PYLL) to include equivalent years of ‘healthy’ life lost by virtue of being in states of poor health or disability (1). The DALY combines in one measure the time lived with disability and the time lost due to premature mortality. One DALY can be thought of as one lost year of ‘healthy’ life and the burden of disease as a measurement of the gap between current health status and an ideal situation where everyone lives into old age free of disease and disability.

DALYs for a disease or health condition are calculated as the sum of the years of life lost due to premature mortality (YLL) in the population and the years lost due to disability (YLD) for incident cases of the health condition: The years of life lost (YLL) basically correspond to the number of deaths multiplied by the standard life expectancy at the age at which death occurs. The basic formula for YLL (without yet including other social preferences discussed below), is the following for a given cause, age and sex:

YLL = N x L where: N = number of deaths L = standard life expectancy at age of death in years

Because YLL measure the incident stream of lost years of life due to deaths, an incidence perspective is also taken for the calculation of YLD. To estimate YLD for a particular cause in a particular time period, the number of incident cases in that period is multiplied by the average duration of the disease and a weight factor that reflects the severity of the disease on a scale from 0 (perfect health) to 1 (dead). The basic formula for YLD is the following (again, without applying social preferences):

YLD = I x DW x L where: I = number of incident cases DW = disability weight L = average duration of the case until remission or death (years)

Egalitarian principles were explicitly built into the DALY, and the Global Burden of Disease Study used the same values for all regions of the world (2) . It used the same life expectancy ‘ideal’ standard for all population subgroups and it excluded all non-health characteristics (such as race, socioeconomic status or occupation) apart from age and sex from consideration in calculating lost years of healthy life. Most importantly, it used the same ‘disability weight’ for everyone living a year in a specified health state. Additionally, 3% time discounting and non-uniform age weights which give less weight to years lived at young and older ages were used in calculating DALYs for the original Global Burden of Disease study. These value choices have continued to be used for the Global Burden of Disease 2000 study results reported in recent World Health Reports and in these tables.

With non-uniform age weights and 3% discounting, a death in infancy corresponds to 33 DALYs, and deaths at ages 5 to 20 to around 36 DALYs. Thus a disease burden of 3,300 DALYs in a population would be the equivalent of 100 infant deaths or to approximately 5,500 persons aged 50 years living one year with blindness (disability weight 0.6).

References 1. Murray CJL, Salomon JA, Mathers CD, Lopez AD (eds.) (2002). Summary measures of population health: concepts, ethics, measurement and applications. WHO, Geneva. Available at http://www.who.int/pub/smph/en/index.html2. Murray CJL, Lopez AD (1996). The Global Burden of Disease. Cambridge: Harvard University Press.

World Health OrganizationOrganisation Mondiale de la Santé

Department of NOTES FOR TABLES

Measurement and Health Information

April 2011

(a)

(b) Underlying cause of death categories are defined in an Annex Table in the Data sources and methods documentation (3).

(c) The data sources and methods used for the estimation of total deaths (all causes), and deaths by cause, for each Member State are summarized in Annex Table 4 of reference (3).

(d)

This workbook contains summary estimates of mortality for WHO Member States for the year 2008. This update of estimates of deaths by cause, age and sex uses the same general methods as previous revisions carried out by WHO for 2002 and 2004 (1,2). Mortality estimates are based on analysis of latest available national information on levels of mortality and cause distributions as at the end of 2010 together with latest available information from WHO programs, IARC and UNAIDS for specific causes of public health importance. Data, methods and cause categories are described in an accompanying text document available on the WHO website (3). Member States were consulted on these estimates in late 2010 and comments or data provided by them were considered and incorporated where appropriate. These summary tables represent the best estimates of WHO – based on evidence available at the end of 2010 – rather than the official estimates of Member States. These estimates have been computed using standard categories and methods to ensure cross-national comparability . Therefore, they are not always the same as official national estimates, nor necessarily endorsed by specific Member States.

Colour codes are used to summarize the levels of evidence for causes of death available for each Member State. Levels of uncertainty are highest for the last category, and caution should be used in comparing mortality levels across these countries for causes without country-specific information.

Reasonably complete death registration data available with underlying cause of death coded using ICD-9 or ICD-10 without excessive use of inappropriate or non-specific codes.

Incomplete death registration data, and/or other forms of nationally representative information on causes of death (eg. verbal autopsy, sample registration data) available. Cause of death models may be used to adjust for biases due to incomplete population coverage, other adjustments made using country-specific information for specific causes.

Country information on causes of death not available for most causes. Cause of death modelling used to estimate broad distribution of causes of death for Groups I, II and III by age and sex for the country level of all cause mortality and per capita income. Cause of death patterns within the three major cause groups based on death registration data from other countries in the region. Further country-level information and data on specific causes listed above was also used. Separate specific multicause models used for the major causes of child death.

Note that levels of evidence will vary for specific causes within a country, and the above colour coded scheme does not attempt to provide that level of detail for specific causes. In general, country-level adjustments were made for cause-specific mortality estimates obtained from WHO technical programmes, IARC, UNAIDS and other sources for the following conditions: AIDS, TB, measles, pertussis, tetanus, dengue, malaria, schistosomiasis, trypanosomiasis, Japanese encephalitis, Chagas, maternal conditions (including abortion), cancers, drug use disorders, rheumathoid arthritis, road traffic accidents and war. See reference (3) for details.

(e)

(f)

(g) Does not include liver cancer and cirrhosis deaths or DALYs resulting from chronic hepatitis virus infection.

(h)

(i) Includes severe neonatal infections and other non-infectious causes arising in the perinatal period.

(j)

(k) Includes myocarditis, pericarditis, endocarditis and cardiomyopathy.

UN estimates of de-facto population (2008 Revision) (4). Estimated death rates by age, sex for underlying causes of death as defined by the ICD classification rules, are applied to the UN estimates of de-facto resident population for 2008 to give numbers of expected deaths by cause for each Member State.

Maternal HIV deaths (deaths during pregnancy or within 42 days of end of pregnancy) exacerbated by HIV infection are classified as maternal deaths and counted there rather than as HIV deaths.

This cause category includes 'Causes arising in the perinatal period' as defined in the International Classification of Diseases, principally low birthweight, prematurity, birth asphyxia and birth trauma, and does not include all disability or deaths occurring in the neonatal period (under 28 days after birth). For example, congenital anomalies and injuries may also occur in the neonatal period but are classified to other cause categories.

Includes macular degeneration and other age-related causes of vision loss not correctable by provision of glasses or contact lenses, together with deaths due to other sense organ disorders.

(m)

Cause-specific death rates were age-standardized to the WHO global standard population (see Discussion Paper 31, http://www.who.int/healthinfo/paper31.pdf). Age-standardized death rates are calculated by applying age-specific death rates for the Member State to a global standard population. Comparison of cause-specific mortality risks across countries is facilitated by the use of age-standardized death rates to adjust for differences in population age distributions.

References1. Lopez AD, Mathers CD, Ezzati M, Murray CJL, Jamison DT. Global burden of disease and risk factors. New York, Oxford University Press, 2006. Available at http://www.dcp2.org/pubs/GBD2. World Health Organization. The global burden of disease: 2004 update. Geneva, World Health Organization, 2008. Available at http://www.who.int/evidence/bod3. World Health Organization. Causes of death 2008: data sources and methods. Geneva, World Health Organization, 2010. Available at http://www.who.int/healthinfo/global_burden_disease/cod_2008_sources_methods.pdf 4. United Nations Population Division. World Population Prospects - the 2008 revision. New York: United Nations, 2009.5. Mathers CD, Salomon JA, Ezzati M, Begg S, Lopez AD. Sensitivity and uncertainty analyses for burden of disease and risk factor estimates. In: Lopez AD, Mathers CD, Ezzati M, Murray CJL, Jamison DT, eds. Global burden of disease and risk factors. New York, OUP, 2006: 399-426. Available at http://www.dcp2.org/pubs/GBD.

04/07/2023 + ^

GBD cause (b) Afghanistan Albania Algeria Andorra Angola Argentina Armenia Australia

WHO Country code 3010 4005 1010 4008 1020 2010 2020 4007 5020

Population ('000) (e) 12,597 761 9,538 12 8,161 24 10,127 632 4,043

0 All Causes (c) 262.4 1.0 27.5 0.0 134.5 0.0 12.8 1.2 1.7

1I.

228.8 0.4 22.5 0.0 121.8 0.0 6.5 0.8 0.8

2 A. Infectious and parasitic diseases 97.6 0.1 7.6 0.0 61.0 0.0 0.8 0.2 0.0

3 1. Tuberculosis 0.7 0.0 0.3 - 0.7 - 0.0 0.0 -

4 2. STDs excluding HIV 0.8 0.0 0.3 - 0.5 - 0.0 0.0 -

5 a. Syphilis 0.8 0.0 0.3 - 0.5 - 0.0 0.0 -

6 b. Chlamydia - - - - - - - - -

7 c. Gonorrhoea 0.0 - - - - - - 0.0 -

9 3. HIV/AIDS (f) 0.0 - 0.0 - 2.9 - 0.0 0.0 -

10 4. Diarrhoeal diseases 61.1 0.0 3.7 0.0 28.1 0.0 0.1 0.0 0.0

11 5. Childhood-cluster diseases 6.1 0.0 0.8 - 3.9 - 0.1 0.0 -

12 a. Pertussis 1.1 - 0.4 - 2.1 - 0.1 - -

13 b. Poliomyelitis 0.0 - - - - - - - -

14 c. Diphtheria 0.1 0.0 0.0 - 0.0 - - 0.0 -

15 d. Measles 2.0 - 0.2 - 1.2 - - - -

16 e. Tetanus 2.9 0.0 0.2 - 0.7 - - - -

17 6. Meningitis 6.4 0.0 0.5 0.0 3.0 - 0.1 0.1 0.0

18 7. Hepatitis B (g) 0.4 0.0 0.0 - 0.1 - 0.0 0.0 -

19 Hepatitis C (g) 0.2 0.0 0.0 - 0.0 - - 0.0 -

20 8. Malaria 0.1 - - - 15.1 - - - -

21 9. Tropical-cluster diseases 0.4 0.0 0.3 - 0.8 - 0.0 - -

22 a. Trypanosomiasis - - 0.1 - 0.6 - - - -

23 b. Chagas disease - - - - - - 0.0 - -

24 c. Schistosomiasis - - - - 0.0 - - - -

25 d. Leishmaniasis 0.4 0.0 0.1 - 0.1 - - - -

26 e. lymphatic filariasis - - - - - - - - -

27 f. Onchocerciasis - - - - - - - - -

28 10. Leprosy 0.0 - - - - - - - -

29 11. Dengue 0.0 - 0.0 - 0.0 - - - -

30 12. Japanese encephalitis - - - - - - - - -

31 13. Trachoma - - - - - - - - -

32 14. Intestinal nematode infections 0.0 - 0.0 - 0.0 - - - -

33 a. Ascariasis - - 0.0 - 0.0 - - - -

34 b. Trichuriasis - - - - - - - - -

35 c. Hookworm disease 0.0 - - - - - - - -

38 B. Respiratory infections 69.9 0.2 5.3 0.0 25.2 0.0 0.6 0.2 0.0

39 1. Lower respiratory infections 68.4 0.2 5.3 0.0 24.7 0.0 0.6 0.2 0.0

40 2. Upper respiratory infections 1.5 0.0 0.1 0.0 0.5 - 0.0 0.0 -

41 3. Otitis media 0.0 - 0.0 - 0.0 - 0.0 - 0.0

42 C. Maternal conditions - - 0.0 - 0.0 - 0.0 - -

49 D. Perinatal conditions (h) 48.0 0.2 9.0 0.0 26.4 0.0 5.1 0.4 0.7

50 1. Prematurity and low birth weight 15.1 0.1 4.8 0.0 9.4 0.0 2.7 0.3 0.2

51 2. Birth asphyxia and birth trauma 17.2 0.1 2.8 0.0 8.6 0.0 0.8 0.1 0.1

52 3. 15.8 0.0 1.5 0.0 8.4 0.0 1.6 0.0 0.4

53 E. Nutritional deficiencies 13.3 0.0 0.5 - 9.2 - 0.1 0.0 -

54 1. Protein-energy malnutrition 9.4 0.0 0.4 - 8.3 - 0.1 0.0 -

55 2. Iodine deficiency 0.2 - 0.0 - 0.0 - - - -

56 3. Vitamin A deficiency 0.0 - 0.0 - 0.6 - - - -

57 4. Iron-deficiency anaemia 1.5 0.0 0.1 - 0.3 - 0.0 0.0 -

59 II. Noncommunicable diseases 19.9 0.5 3.3 0.0 7.3 0.0 4.9 0.3 0.7

60 A. Malignant neoplasms 0.9 0.1 0.7 0.0 0.4 0.0 0.4 0.1 0.1

61 1. Mouth and oropharynx cancers 0.0 0.0 0.0 - 0.0 - 0.0 - -

62 2. Oesophagus cancer - - - - - - 0.0 - -

63 3. Stomach cancer - 0.0 0.0 - 0.0 - - - -

64 4. Colon and rectum cancers 0.0 0.0 0.0 - - - - - -

65 5. Liver cancer 0.0 - 0.0 - 0.0 - 0.0 0.0 0.0

66 6. Pancreas cancer - - 0.0 - 0.0 - - - -

67 7. Trachea, bronchus, lung cancers - 0.0 0.0 - 0.0 0.0 0.0 - 0.0

68 8. Melanoma and other skin cancers - 0.0 - - - - 0.0 - 0.0

69 9. Breast cancer - - 0.0 - 0.0 - - - -

70 10. Cervix uteri cancer - - - - 0.0 - - - -

GBD code

Antigua and Barbuda

Communicable, maternal, perinatal and nutritional conditions

Neonatal infections and other conditions (i)

04/07/2023 + ^

71 11. Corpus uteri cancer - - - - - - 0.0 - -

72 12. Ovary cancer 0.0 0.0 0.0 - 0.0 - - 0.0 -

73 13. Prostate cancer 0.0 - - - 0.0 - 0.0 - -

74 14. Bladder cancer - - - - - - 0.0 - -

75 15. Lymphomas, multiple myeloma 0.2 0.0 0.2 0.0 0.1 - 0.0 0.0 0.0

76 16. Leukaemia 0.4 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0

78 B. Other neoplasms 0.1 0.0 0.0 0.0 0.1 0.0 0.1 - 0.0

79 C. Diabetes mellitus 0.1 - 0.0 - 0.0 - 0.0 0.0 0.0

80 D. Endocrine disorders 0.9 0.0 0.1 0.0 0.5 0.0 0.2 0.0 0.0

81 E. Neuropsychiatric conditions 1.1 0.1 0.2 0.0 1.0 0.0 0.4 0.0 0.1

82 1. Unipolar depressive disorders - - - - - - - 0.0 -

83 2. Bipolar disorder - - - - - - - 0.0 -

84 3. Schizophrenia 0.0 0.0 - - - - 0.0 0.0 -

85 4. Epilepsy 0.3 0.1 0.1 - 0.4 - 0.1 0.0 0.0

86 5. Alcohol use disorders 0.0 - 0.0 - 0.0 - - 0.0 -

87 6. Alzheimer and other dementias 0.0 0.0 0.0 0.0 0.0 - 0.0 0.0 0.0

88 7. Parkinson disease 0.0 0.0 - - - - 0.0 0.0 -

89 8. Multiple sclerosis 0.0 - - - - - - - -

90 9. Drug use disorders 0.0 - - - - - - 0.0 0.0

91 10. Post-traumatic stress disorder - - - - - - - 0.0 -

92 11. Obsessive-compulsive disorder - - - - - - - - -

93 12. Panic disorder - - - - - - - - -

94 13. Insomnia (primary) - - - - - - - - -

95 14. Migraine - - - - - - - - -

98 F. Sense organ diseases 0.0 0.0 0.0 - 0.0 - - - -

99 1. Glaucoma - - - - - - - - -

100 2. Cataracts - - - - - - - - -

101 3. Refractive errors - - - - - - - - -

102 4. Hearing loss, adult onset - - - - - - - - -

103 5. Macular degeneration and other (j) 0.0 0.0 0.0 - 0.0 - - - -

104 G. Cardiovascular diseases 7.1 0.1 0.3 0.0 0.8 0.0 0.3 0.0 0.0

105 1. Rheumatic heart disease 0.4 0.0 0.0 - 0.1 - - - -

106 2. Hypertensive heart disease 0.2 0.0 0.0 - 0.0 - 0.0 - -

107 3. Ischaemic heart disease 0.3 0.0 0.0 - 0.0 - 0.0 - 0.0

108 4. Cerebrovascular disease 2.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0

109 5. Inflammatory heart diseases (k) 0.3 0.0 0.1 0.0 0.4 - 0.1 0.0 0.0

111 H. Respiratory diseases 1.3 0.0 0.1 0.0 0.9 0.0 0.5 0.0 0.0

112 1. Chronic obstructive pulmonary disease - 0.0 0.0 - 0.1 - 0.0 0.0 0.0

113 2. Asthma 0.1 0.0 0.0 - 0.1 0.0 0.0 0.0 0.0

115 I. Digestive diseases 1.2 0.0 0.1 0.0 0.4 - 0.1 0.0 0.0

116 1. Peptic ulcer disease 0.0 - 0.0 - 0.0 - - - -

117 2. Cirrhosis of the liver 0.3 - 0.0 - 0.0 - - - -

118 3. Appendicitis 0.0 0.0 0.0 - 0.0 - 0.0 - -

120 J. Genitourinary diseases 0.5 0.0 0.1 - 0.3 - 0.1 0.0 0.0

121 1. Nephritis and nephrosis 0.4 0.0 0.1 - 0.3 - 0.0 0.0 0.0

122 2. Benign prostatic hypertrophy - - - - - - - - -

124 K. Skin diseases 0.0 - 0.0 - 0.0 - 0.0 - -

125 L. Musculoskeletal diseases 0.0 0.0 0.0 - 0.0 - 0.0 - 0.0

126 1. Rheumatoid arthritis 0.0 0.0 - - - - 0.0 - -

127 2. Osteoarthritis - 0.0 - - - - - - -

131 M. Congenital anomalies 6.6 0.2 1.7 0.0 2.7 0.0 2.8 0.2 0.3

143 N. Oral conditions 0.0 - 0.0 - 0.0 - - - -

144 1. Dental caries - - - - - - - - -

145 2. Periodontal disease - - 0.0 - 0.0 - - - -

146 3. Edentulism - - - - - - - - -

148 III.Injuries 13.7 0.2 1.7 0.0 5.4 0.0 1.4 0.1 0.2

149 A. Unintentional injuries 11.9 0.2 1.5 0.0 5.0 0.0 1.2 0.1 0.2

150 1. Road traffic accidents 2.8 0.0 0.6 0.0 1.4 - 0.3 0.0 0.1

151 2. Poisonings 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0

152 3. Falls 1.1 0.0 0.1 0.0 0.2 - 0.0 0.0 0.0

153 4. Fires 0.6 0.0 0.3 0.0 1.1 - 0.1 0.0 0.0

154 5. Drownings 2.2 0.0 0.2 0.0 0.2 - 0.2 0.0 0.0

155 6. Other unintentional injuries 4.9 0.1 0.3 0.0 2.0 0.0 0.5 0.0 0.1

156 B. Intentional injuries 1.8 0.0 0.2 0.0 0.4 - 0.1 0.0 0.0

157 1. Self-inflicted injuries 0.0 0.0 0.0 - 0.0 - 0.1 0.0 0.0

158 2. Violence 0.2 0.0 0.1 0.0 0.3 - 0.1 0.0 0.0

159 3. War 1.5 - 0.1 - 0.0 - - - -

Refer to Notes sheet for notes on this table.

Population ('000) (e) 6,503 393 4,877 6 4,066 12 5,149 338 2,075

04/07/2023 + ^


WHO Country code 3010 4005 1010 4008 1020 2010 2020 4007 5020

Population ('000) (e) 13,581 1,970 22,549 54 9,154 53 23,992 2,006 13,092

0 All Causes (c) 114.7 4.3 45.8 0.1 68.8 0.2 59.5 7.2 18.6

1I.

40.3 0.1 7.9 0.0 36.9 0.0 6.2 0.6 0.5


3 1. Tuberculosis 6.3 0.0 0.9 0.0 2.9 0.0 0.3 0.3 0.0

4 2. STDs excluding HIV 0.3 - 0.0 - 0.1 - 0.0 0.0 -

5 a. Syphilis 0.0 - 0.0 - 0.0 - - - -

6 b. Chlamydia 0.1 - 0.0 - 0.0 - - - -

7 c. Gonorrhoea 0.0 - 0.0 - 0.0 - - - -

9 3. HIV/AIDS (f) - 0.0 0.6 - 8.7 0.0 1.4 0.1 0.1


11 5. Childhood-cluster diseases 0.5 0.0 0.0 - 0.0 - 0.0 0.0 0.0

12 a. Pertussis - - 0.0 - 0.0 - - - -

13 b. Poliomyelitis - - 0.0 - 0.0 - 0.0 - -

14 c. Diphtheria - 0.0 - - - - - - 0.0

15 d. Measles - - 0.0 - 0.0 - - 0.0 -

16 e. Tetanus 0.5 - 0.0 - 0.0 - 0.0 - -

17 6. Meningitis 0.5 0.0 0.5 0.0 1.6 0.0 0.2 0.0 0.0

18 7. Hepatitis B (g) 0.8 0.0 0.1 0.0 0.2 - 0.0 0.0 0.0

19 Hepatitis C (g) 0.4 0.0 0.0 0.0 0.1 - 0.1 0.0 0.0

20 8. Malaria 0.0 - - - 0.9 - - - -

21 9. Tropical-cluster diseases 0.1 - 0.1 - 1.4 - 0.1 - -

22 a. Trypanosomiasis 0.0 - - - 0.9 - - - -

23 b. Chagas disease - - - - - - 0.1 - -


25 d. Leishmaniasis 0.1 - 0.1 - 0.1 - - - -

26 e. lymphatic filariasis 0.0 - - - - - - - -

27 f. Onchocerciasis - - 0.0 - 0.0 - - - -

28 10. Leprosy - - 0.0 0.0 0.0 - 0.0 - -

29 11. Dengue 0.0 - 0.0 - 0.0 - - 0.0 -


31 13. Trachoma - - - - - - - - -

32 14. Intestinal nematode infections 0.0 0.0 0.0 - 0.0 - 0.0 - -

33 a. Ascariasis 0.0 - 0.0 - 0.0 - - - -

34 b. Trichuriasis - - - - - - - - -

35 c. Hookworm disease - - - - - - - - -



40 2. Upper respiratory infections 0.0 0.0 0.0 - 0.2 - 0.0 - 0.0

41 3. Otitis media - 0.0 0.0 - 0.1 - - - -

42 C. Maternal conditions 17.7 0.0 0.9 0.0 4.8 0.0 0.5 0.0 0.0

49 D. Perinatal conditions (h) - - - 0.0 - - - - -

50 1. Prematurity and low birth weight - - - - - - - - -

51 2. Birth asphyxia and birth trauma - - - 0.0 - - - - -

52 3. - - - 0.0 - - - - -

53 E. Nutritional deficiencies 0.6 0.0 0.4 0.0 0.9 0.0 0.1 0.0 0.0

54 1. Protein-energy malnutrition 0.4 - 0.2 0.0 0.7 - 0.1 0.0 0.0

55 2. Iodine deficiency 0.0 - 0.0 - 0.0 - 0.0 - -

56 3. Vitamin A deficiency 0.0 - 0.0 - 0.0 - - - -

57 4. Iron-deficiency anaemia 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0



61 1. Mouth and oropharynx cancers 0.1 0.0 0.5 0.0 0.1 0.0 0.3 0.0 0.2

62 2. Oesophagus cancer 0.4 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2

63 3. Stomach cancer 0.6 0.2 0.6 0.0 0.2 0.0 0.9 0.2 0.2

64 4. Colon and rectum cancers 0.4 0.1 1.0 0.0 0.2 0.0 1.5 0.1 0.7

65 5. Liver cancer 0.2 0.0 0.1 0.0 0.6 0.0 0.3 0.1 0.2

66 6. Pancreas cancer 0.1 0.1 0.1 0.0 0.1 0.0 0.7 0.1 0.3

67 7. Trachea, bronchus, lung cancers 0.3 0.2 1.1 0.0 0.1 0.0 2.6 0.4 1.2

68 8. Melanoma and other skin cancers 0.1 0.0 0.0 0.0 0.1 - 0.3 - 0.4

69 9. Breast cancer 0.6 0.2 1.6 0.0 0.4 0.0 1.9 0.3 1.0

70 10. Cervix uteri cancer 0.2 0.0 0.4 0.0 0.6 0.0 1.2 0.1 0.1

GBD code

Antigua and Barbuda



04/07/2023 + ^

71 11. Corpus uteri cancer 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1

72 12. Ovary cancer 0.1 0.0 0.3 0.0 0.1 0.0 0.4 0.0 0.2

73 13. Prostate cancer 0.0 0.0 0.1 0.0 0.1 - 0.2 0.0 0.1

74 14. Bladder cancer 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1

75 15. Lymphomas, multiple myeloma 0.7 0.0 1.2 0.0 0.3 0.0 0.8 0.0 0.4

76 16. Leukaemia 0.5 0.1 0.4 0.0 0.1 0.0 0.6 0.1 0.3

78 B. Other neoplasms 1.4 0.1 0.2 0.0 0.2 0.0 0.7 0.0 0.1

79 C. Diabetes mellitus 1.0 0.0 1.4 0.0 1.3 0.0 1.3 0.3 0.3



82 1. Unipolar depressive disorders 0.0 0.0 0.0 - 0.0 - 0.0 0.0 0.0

83 2. Bipolar disorder - 0.0 0.0 0.0 0.0 - 0.0 - 0.0

84 3. Schizophrenia 0.0 0.0 0.0 0.0 0.0 - 0.0 0.0 0.0

85 4. Epilepsy 0.5 0.0 0.6 0.0 0.6 0.0 0.2 0.0 0.2

86 5. Alcohol use disorders 0.1 - 0.1 0.0 0.1 0.0 0.4 0.0 0.1

87 6. Alzheimer and other dementias 0.0 0.0 0.0 0.0 0.0 - 0.1 0.0 0.0

88 7. Parkinson disease 0.0 0.0 0.0 0.0 0.0 - 0.0 0.0 0.0

89 8. Multiple sclerosis 0.0 0.0 0.0 0.0 0.0 - 0.1 0.0 0.1

90 9. Drug use disorders 5.0 0.0 0.1 0.0 0.0 - 0.0 0.0 0.1

91 10. Post-traumatic stress disorder - - - - - - - 0.0 -

92 11. Obsessive-compulsive disorder - - - - - - - - -

93 12. Panic disorder - - - - - - - - -


95 14. Migraine - - - - - - - - -

98 F. Sense organ diseases 0.0 0.0 0.0 - 0.0 - - 0.0 -

99 1. Glaucoma - - - - - - - - -

100 2. Cataracts - - - - - - - - -



103 5. Macular degeneration and other (j) 0.0 0.0 0.0 - 0.0 - - 0.0 -


105 1. Rheumatic heart disease 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0

106 2. Hypertensive heart disease 2.2 0.0 0.6 0.0 0.5 0.0 0.5 0.1 0.1

107 3. Ischaemic heart disease 13.9 0.7 2.6 0.0 2.3 0.0 5.0 1.5 1.9


109 5. Inflammatory heart diseases (k) 0.9 0.0 0.5 0.0 0.5 0.0 0.6 0.0 0.3


112 1. Chronic obstructive pulmonary disease 0.9 0.0 0.9 0.0 0.8 0.0 0.5 0.1 0.2

113 2. Asthma 2.0 0.0 0.7 0.0 0.6 0.0 0.1 0.0 0.1

115 I. Digestive diseases 5.5 0.1 2.8 0.0 2.7 0.0 3.9 0.5 0.9

116 1. Peptic ulcer disease 0.2 0.0 0.3 0.0 0.3 - 0.1 0.0 0.0

117 2. Cirrhosis of the liver 2.6 - 0.4 0.0 0.4 0.0 1.4 0.3 0.5

118 3. Appendicitis 0.0 0.0 0.0 0.0 0.0 - 0.0 0.0 0.0

120 J. Genitourinary diseases 3.3 0.1 1.0 0.0 1.0 0.0 1.1 0.2 0.1

121 1. Nephritis and nephrosis 3.0 0.1 0.9 0.0 0.9 0.0 0.9 0.2 0.1

122 2. Benign prostatic hypertrophy 0.0 0.0 0.0 - 0.0 - - - -

124 K. Skin diseases 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0

125 L. Musculoskeletal diseases 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1

126 1. Rheumatoid arthritis 0.0 0.0 0.0 0.0 0.0 - 0.1 0.0 0.0

127 2. Osteoarthritis 0.0 - 0.0 - 0.0 - 0.0 0.0 0.0

131 M. Congenital anomalies 0.4 0.0 0.1 0.0 0.1 - 0.2 0.0 0.1

143 N. Oral conditions 0.0 - 0.0 0.0 0.0 - 0.0 - 0.0

144 1. Dental caries - - - - - - - - -

145 2. Periodontal disease - - 0.0 - 0.0 - - - -

146 3. Edentulism - - - - - - - - -

148 III.Injuries 20.5 1.0 7.8 0.0 9.7 0.0 13.0 1.0 4.4


150 1. Road traffic accidents 3.4 0.2 2.2 0.0 3.0 0.0 3.7 0.3 1.1

151 2. Poisonings 0.6 0.1 0.4 0.0 0.6 0.0 0.2 0.0 0.6

152 3. Falls 0.4 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.1

153 4. Fires 0.6 0.0 0.2 0.0 0.2 0.0 0.2 0.0 0.0

154 5. Drownings 0.8 0.0 0.3 0.0 0.4 0.0 0.4 0.0 0.1


156 B. Intentional injuries 12.8 0.3 3.3 0.0 3.9 0.0 5.0 0.2 1.6

157 1. Self-inflicted injuries 1.0 0.2 0.6 0.0 0.8 0.0 2.9 0.1 1.4

158 2. Violence 0.5 0.1 2.1 0.0 2.9 0.0 2.1 0.1 0.2

159 3. War 11.2 - 0.6 - 0.1 - - - -


Population ('000) (e) 7,079 969 11,433 27 4,500 26 12,009 923 6,562

04/07/2023 + ^


WHO Country code 3010 4005 1010 4008 1020 2010 2020 4007 5020

Population ('000) (e) 1,030 413 2,286 19 706 10 5,764 440 3,940

0 All Causes (c) 61.5 22.4 100.5 0.6 42.0 0.4 250.6 33.5 120.5

1I.

6.6 0.9 21.1 0.0 10.0 0.0 31.2 1.0 4.9


3 1. Tuberculosis 2.3 0.0 0.2 0.0 0.6 0.0 0.4 0.1 0.1

4 2. STDs excluding HIV 0.1 0.0 0.4 0.0 0.2 - 0.0 0.0 0.0

5 a. Syphilis 0.0 0.0 0.1 0.0 0.0 - 0.0 - 0.0

6 b. Chlamydia 0.0 - - - - - - - -

7 c. Gonorrhoea 0.0 - 0.0 - 0.0 - - - -

9 3. HIV/AIDS (f) - 0.0 0.0 - 0.2 0.0 0.1 0.0 0.0


11 5. Childhood-cluster diseases 0.1 - 0.0 0.0 0.0 - 0.0 - 0.0

12 a. Pertussis - - 0.0 - 0.0 - - - 0.0

13 b. Poliomyelitis - - 0.0 0.0 0.0 - 0.0 - 0.0

14 c. Diphtheria 0.0 - 0.0 - 0.0 - - - -

15 d. Measles - - - - - - - - -

16 e. Tetanus 0.1 - 0.0 0.0 0.0 - 0.0 - -

17 6. Meningitis 0.0 0.0 0.3 0.0 0.2 - 0.1 0.0 0.0

18 7. Hepatitis B (g) 0.2 0.0 0.0 0.0 0.0 - 0.0 0.0 0.0

19 Hepatitis C (g) 0.1 0.0 0.0 0.0 0.0 - 0.1 - 0.0

20 8. Malaria 0.0 - - - 0.1 - - - -

21 9. Tropical-cluster diseases 0.0 0.0 0.0 0.0 0.4 - 0.3 - -

22 a. Trypanosomiasis - - - - 0.1 - - - -

23 b. Chagas disease - - - - - - 0.3 - -


25 d. Leishmaniasis - 0.0 0.0 0.0 0.0 - 0.0 - -

26 e. lymphatic filariasis 0.0 0.0 - - - - - - -

27 f. Onchocerciasis - - 0.0 - 0.0 - - - -

28 10. Leprosy 0.0 - 0.0 - 0.0 0.0 0.0 - -

29 11. Dengue 0.0 - 0.0 - 0.0 - - - -


31 13. Trachoma - - - - - - - - -

32 14. Intestinal nematode infections 0.0 - - - - - - - -

33 a. Ascariasis - - - - - - - - -

34 b. Trichuriasis - - - - - - - - -

35 c. Hookworm disease - - - - - - - - -



40 2. Upper respiratory infections 0.0 0.0 0.1 0.0 0.0 - 0.0 0.0 0.0

41 3. Otitis media 0.0 - 0.0 0.0 0.0 0.0 - - 0.0

42 C. Maternal conditions - - - - - - - - -

49 D. Perinatal conditions (h) - 0.0 - - - - - - -

50 1. Prematurity and low birth weight - - - - - - - - -

51 2. Birth asphyxia and birth trauma - 0.0 - - - - - - -

52 3. - 0.0 - - - - - - -

53 E. Nutritional deficiencies 0.1 0.0 0.9 0.0 0.1 0.0 1.5 0.0 0.2

54 1. Protein-energy malnutrition 0.0 0.0 0.2 0.0 0.1 0.0 1.1 0.0 0.1

55 2. Iodine deficiency 0.0 - - - - - - - -

56 3. Vitamin A deficiency 0.0 0.0 - - - - - - -

57 4. Iron-deficiency anaemia 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.1



61 1. Mouth and oropharynx cancers 0.1 0.1 0.3 0.0 0.1 0.0 0.8 0.1 0.5

62 2. Oesophagus cancer 0.6 0.1 0.1 0.0 0.2 0.0 1.9 0.1 1.1

63 3. Stomach cancer 1.0 0.5 0.8 0.0 0.1 0.0 2.8 0.4 1.1

64 4. Colon and rectum cancers 0.3 0.2 1.0 0.0 0.1 0.0 7.0 0.4 3.8

65 5. Liver cancer 0.2 0.2 0.1 0.0 0.2 0.0 1.6 0.4 0.9

66 6. Pancreas cancer 0.1 0.2 0.2 0.0 0.0 0.0 3.6 0.3 1.8

67 7. Trachea, bronchus, lung cancers 0.4 0.9 1.3 0.0 0.1 0.0 7.4 1.1 6.5

68 8. Melanoma and other skin cancers 0.1 0.0 0.0 0.0 0.0 0.0 0.7 - 1.5

69 9. Breast cancer 0.2 0.1 0.6 0.0 0.2 0.0 4.8 0.3 2.2

70 10. Cervix uteri cancer 0.1 0.0 0.4 0.0 0.4 0.0 1.0 0.1 0.2

GBD code

Antigua and Barbuda



04/07/2023 + ^

71 11. Corpus uteri cancer 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.3

72 12. Ovary cancer 0.0 0.0 0.1 0.0 0.1 0.0 0.9 0.1 0.7

73 13. Prostate cancer 0.1 0.2 0.5 0.0 0.4 0.0 4.8 0.2 3.4

74 14. Bladder cancer 0.2 0.1 0.7 0.0 0.1 0.0 1.5 0.2 1.0

75 15. Lymphomas, multiple myeloma 0.3 0.1 0.7 0.0 0.1 0.0 1.8 0.0 2.3

76 16. Leukaemia 0.2 0.1 0.2 0.0 0.0 0.0 1.2 0.1 1.4

78 B. Other neoplasms 0.5 0.2 0.3 0.0 0.1 0.0 2.1 0.1 1.0

79 C. Diabetes mellitus 1.5 0.2 5.2 0.0 2.4 0.0 7.6 2.9 3.6



82 1. Unipolar depressive disorders - 0.0 0.0 0.0 0.0 - 0.0 0.0 0.1

83 2. Bipolar disorder - 0.0 0.0 0.0 0.0 - 0.0 - 0.0

84 3. Schizophrenia 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

85 4. Epilepsy 0.0 0.0 0.5 0.0 0.2 0.0 0.1 0.0 0.1

86 5. Alcohol use disorders 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2

87 6. Alzheimer and other dementias 0.1 0.1 1.1 0.0 0.4 0.0 3.5 0.2 7.3

88 7. Parkinson disease 0.0 0.1 0.2 0.0 0.1 0.0 0.9 0.2 1.1

89 8. Multiple sclerosis 0.0 0.1 0.0 0.0 0.0 - 0.0 - 0.1

90 9. Drug use disorders 0.0 0.0 0.0 - 0.0 - 0.0 0.0 0.0

91 10. Post-traumatic stress disorder - 0.0 - - - - - 0.0 -

92 11. Obsessive-compulsive disorder - - - - - - 0.0 - -

93 12. Panic disorder - - - - - - - - -


95 14. Migraine - - - - - - - - -

98 F. Sense organ diseases 0.1 0.0 0.0 0.0 0.0 - - - 0.0

99 1. Glaucoma - 0.0 - 0.0 - - - - 0.0

100 2. Cataracts - 0.0 - - - - - - -



103 5. Macular degeneration and other (j) 0.1 0.0 0.0 0.0 0.0 - - - 0.0


105 1. Rheumatic heart disease 0.2 0.0 0.1 0.0 0.0 - 0.1 0.1 0.3

106 2. Hypertensive heart disease 4.2 1.0 2.7 0.0 1.0 0.0 6.0 1.1 1.6

107 3. Ischaemic heart disease 17.0 4.7 12.1 0.1 5.3 0.1 31.4 9.1 23.0


109 5. Inflammatory heart diseases (k) 1.0 0.2 1.3 0.0 0.5 0.0 2.8 0.2 0.9


112 1. Chronic obstructive pulmonary disease 2.1 0.3 4.2 0.0 1.9 0.0 4.6 1.9 4.9

113 2. Asthma 0.1 0.3 1.3 0.0 0.6 0.0 0.4 0.2 0.4

115 I. Digestive diseases 5.1 0.4 4.2 0.0 1.9 0.0 10.8 1.9 3.9

116 1. Peptic ulcer disease 0.2 0.0 0.6 0.0 0.3 0.0 0.3 0.2 0.3

117 2. Cirrhosis of the liver 2.4 - 0.5 0.0 0.3 0.0 1.6 0.8 0.5

118 3. Appendicitis 0.0 0.0 0.0 0.0 0.0 0.0 0.0 - 0.0

120 J. Genitourinary diseases 2.8 0.3 2.5 0.0 1.0 0.0 9.1 1.2 3.4

121 1. Nephritis and nephrosis 2.6 0.2 2.1 0.0 0.9 0.0 6.8 0.8 2.4

122 2. Benign prostatic hypertrophy 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1

124 K. Skin diseases 0.1 0.0 0.5 0.0 0.2 0.0 1.4 0.1 0.3

125 L. Musculoskeletal diseases 0.1 0.1 0.8 0.0 0.3 0.0 0.7 0.1 1.1

126 1. Rheumatoid arthritis 0.0 0.0 0.1 0.0 0.0 - 0.2 0.0 0.2

127 2. Osteoarthritis 0.0 - 0.1 0.0 0.0 - 0.1 0.0 0.1

131 M. Congenital anomalies 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1

143 N. Oral conditions 0.0 0.0 0.0 0.0 0.0 - 0.0 - 0.0

144 1. Dental caries - - 0.0 - 0.0 - - - -

145 2. Periodontal disease - - 0.0 - 0.0 - - - 0.0

146 3. Edentulism - - - - - - - - -

148 III.Injuries 2.1 0.4 3.8 0.0 1.4 0.0 5.9 0.7 3.3


150 1. Road traffic accidents 0.3 0.1 1.2 0.0 0.5 - 0.8 0.1 0.3

151 2. Poisonings 0.0 0.0 0.3 0.0 0.1 - 0.1 0.1 0.1

152 3. Falls 0.1 0.0 0.5 0.0 0.2 0.0 0.2 0.1 1.2

153 4. Fires 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0

154 5. Drownings 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0


156 B. Intentional injuries 1.3 0.0 0.8 0.0 0.3 - 1.0 0.0 0.4

157 1. Self-inflicted injuries 0.0 0.0 0.4 0.0 0.1 - 0.8 0.0 0.4

158 2. Violence 0.0 0.0 0.3 0.0 0.1 - 0.3 0.0 0.0

159 3. War 1.3 - 0.1 - 0.0 - - - -


Population ('000) (e) 510 190 1,042 8 318 5 2,402 174 1,838

Copy of Global Burden Disease Death Estimates Sex Age 2008

Documents

Transcript of Copy of Global Burden Disease Death Estimates Sex Age 2008